← All trials
NCT05064618
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 23, 2021
- Primary completion
- Apr 30, 2025
- Completion date
- Apr 30, 2025
- First posted
- Oct 1, 2021
- Last posted
- Oct 1, 2021
- Enrollment
- 55
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Nagoya UniversityLead sponsor
- Nagoya UniversityReponsible party - principal investigator
- Nagoya UniversityOverall official - principal investigator
- Japan Agency for Medical Research and DevelopmentCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.